Stephenson Brian C

Chief Financial OfficerFaeth Therapeutics, Inc. (FTH) · full profile →Form 4 · filed Jul 2, 2026
Net Buying
Open-Market Buys
$326K
Open-Market Sells
$0
Net Open-Market Flow
$326K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Buy(P)4K$23.40$103K46K
Jul 1, 2026Buy(P)600$24.22$15K47K
Jun 30, 2026Buy(P)2K$22.95$44K36K
Jun 30, 2026Buy(P)2K$23.88$39K37K
Jun 30, 2026Buy(P)4K$24.98$106K42K
Jun 29, 2026Buy(P)831$23.34$19K34K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780030-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about FTH insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001780030-26-000006"
Ask your agent
Use Arkolith to summarize insider buying and selling at Faeth Therapeutics, Inc.
over the last 90 days and cite the filings.